LDOC1 Antikörper (AA 65-146) (Cy7)
Kurzübersicht für LDOC1 Antikörper (AA 65-146) (Cy7) (ABIN717842)
Target
Alle LDOC1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 65-146
-
Homologie
- Human,Dog,Pig,Horse,Rabbit
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human LDOC1
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- LDOC1 (Leucine Zipper, Down-Regulated in Cancer 1 (LDOC1))
-
Andere Bezeichnung
- LDOC1
-
Hintergrund
-
Synonyms: Mar7, BCUR1, Mart7, Protein LDOC1, Leucine zipper protein down-regulated in cancer cells, LDOC1
Background: May have an important role in the development and/or progression of some cancers.
-
Gen-ID
- 23641
-
UniProt
- O95751
Target
-